INNER MONGOLIA CHANGSHENG PHARMACEUTICAL CO LTD

Overview

INNER MONGOLIA CHANGSHENG PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 11 active FDA Type II Drug Master Files, covering 6-AMINOPENICILLANIC ACID; 7-AMINOCEPHALOSPORANIC ACID; AMOXICILLIN TRIHYDRATE; AMPICILLIN ANHYDROUS; AMPICILLIN TRIHYDRATE; AMPICILLIN TRIHYDRATE (COMPACTED).

API / Drug Master Files

INNER MONGOLIA CHANGSHENG PHARMACEUTICAL CO LTD holds 11 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• AMPICILLIN TRIHYDRATE (COMPACTED)Active2025-02-26
• AMPICILLIN ANHYDROUSActive2024-04-06
• ESLICARBAZEPINE ACETATEActive2023-12-08
• SULBACTAM ACIDActive2023-06-28
• AMOXICILLIN TRIHYDRATEActive2023-01-19
• PIPERACILLINActive2021-04-29
• AMPICILLIN TRIHYDRATEActive2021-03-26
• DEACETYL-7-AMINOCEPHALOSPORANIC ACID (D-7-ACA)Active2021-02-25
• PENICILLIN G POTASSIUM (FIRST CRYSTAL)Active2020-05-29
• 7-AMINOCEPHALOSPORANIC ACIDActive2019-07-28
• 6-AMINOPENICILLANIC ACIDActive2006-06-19

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to INNER MONGOLIA CHANGSHENG PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.